Head of Investor Relations
Cohance Lifesciences Limited
Equibles does not estimate personal net worth.
Cinderella Carvalho is recorded as Head of Investor Relations at Cohance Lifesciences Limited. Cinderella Carvalho has spoken on 3 earnings calls across 1 company, most recently for Cohance Lifesciences Limited on November 6, 2026. Cohance Lifesciences Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“Good evening, ladies and gentlemen, and thank you for joining the Kohan Life Sciences Earnings Conference Hall to discuss our financial results in the second quarter and the first half of FY27.”
“Today with me, I have our Executive Chairman and Group CEO, Mr. Umang Gora, Mr. Yan Deerb, CEO, Pharma CDMO, Mr. Gunjan Singh, CEO, API Plus, Mr. Amrit Singh, CEO, Speciality Chemicals.”
“And thank you for joining Kohans Life Sciences, Cotter 4 and F526 Earnings Call. Today, we welcome our Executive Chairman and Group CEO, Mr. Uma Gora, on his first Earnings Call with Kohans.”
Cohance Lifesciences Limited
Head of Investor Relations
Transcript header (unverified)
Cohance Lifesciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
Earnings Call for the Quarter Ended September 30, 2026
Cohance Lifesciences Limited
Earnings Call
Cohance Lifesciences Limited
Earnings Call for the Quarter Ended March 31, 2026
Cohance Lifesciences Limited
